Dmitry Rogachev National Research Center
Dmitry Rogachev National Research Center
Moscow, Russia1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Nivolumab and DA-EPOCH-R in Pediatric Primary Mediastinal (Thymic) Large B-cell Lymphoma | Children; Nivolumab; Primary Mediastinal (Thymic) Large B-cell Lymphoma | Enrolling by invitation | Phase 1 / Phase 2 | 2025-03-11 | NCT06871007 |